ETH-LAD, scientifically known as 6-ethyl-6-nor-lysergic acid diethylamide, represents an analog of LSD. Alexander Shulgin initially documented its effects on human psychopharmacology in the renowned book TiHKAL. ETH-LAD falls into the category of psychedelic substances akin to LSD but exhibits slightly higher potency, with reported active doses ranging from 20 to 150 micrograms. Notably, ETH-LAD offers a distinct experience compared to LSD, often described as less psychologically intense.

IUPAC name
CAS Number65527-62-0 
PubChem CID44457783
CompTox Dashboard (EPA)DTXSID90215823
Chemical and physical data
Molar mass337.467 g·mol−1


On June 10, 2014, the UK Advisory Council on the Misuse of Drugs (ACMD) proposed that ETH-LAD should be explicitly categorized as a class A drug under the UK Misuse of Drugs Act. This recommendation was made despite no prior evidence of its sale or any associated harm. The UK Home Office endorsed this suggestion, leading to the substance being prohibited starting from January 6, 2015.

In Switzerland, ETH-LAD was declared illegal in December 2015.


  • What is ETH-LAD?
  • ETH-LAD, or 6-ethyl-6-nor-lysergic acid diethylamide, is a psychedelic drug analog of LSD (lysergic acid diethylamide). Alexander Shulgin described it in TiHKAL (Tryptamines I Have Known And Loved).
  • How does ETH-LAD compare to LSD?
  • ETH-LAD is similar to LSD but is reported to be slightly more potent, with an active dose ranging from 20 to 150 micrograms. It also has subtly different effects, often described as being less demanding.
  • Is ETH-LAD legal in the United Kingdom?
  • No, ETH-LAD is illegal in the United Kingdom. It was classified as a class A drug under the Misuse of Drugs Act in January 2015.
  • Is ETH-LAD legal in Switzerland?
  • No, ETH-LAD is illegal in Switzerland as of December 2015.
  • What are the effects of ETH-LAD?
  • ETH-LAD produces psychedelic effects similar to LSD, including alterations in perception, mood, and consciousness. The specific products can vary from person to person.
  • Is ETH-LAD considered a research chemical?
  • ETH-LAD was initially used for research purposes, but due to its classification as a controlled substance in many countries, it is no longer considered a legal research chemical.
  • Are there any known risks or side effects associated with ETH-LAD use?
  • As with any psychedelic substance, there are potential risks associated with ETH-LAD use, including psychological distress, anxiety, and hallucinations. It can also affect individuals differently, so caution is advised.
  • Is there ongoing research on ETH-LAD?
  • Research on ETH-LAD is limited due to its legal status in many countries. However, some scientific studies may explore its pharmacological properties and effects.
  • Can ETH-LAD be detected in drug tests?
  • Standard drug tests typically do not screen for ETH-LAD precisely. However, it may be detected if a laboratory conducts a specialized test.
  • Is there a recommended safe dosage for ETH-LAD?
  • ETH-LAD has no universally safe dosage, and its effects can vary widely among individuals. If you use it, start with a low dose and exercise extreme caution.
  • Is ETH-LAD addictive?
  • There is no evidence to suggest that ETH-LAD is physically addictive. However, like other psychedelics, it does not typically lead to physical dependence but can be habit-forming in terms of psychological use.
  • Is it legal to buy ETH-LAD online?
  • In many countries, ETH-LAD is a controlled substance, making its purchase, possession, or sale illegal. It is essential to be aware of and comply with your local drug laws and regulations.


  1. Décret du 20 mai 2021 modifiant la réglementation sur les substances classées comme stupéfiants. Ce décret a été publié dans le Journal officiel de la République française le 20 mai 2021 et concerne la liste des substances classées comme stupéfiants en France.
  2. Synthèse et propriétés stimulantes analogues au LSD dans une série de dérivés de N(6)-alkyle de la norlysergic acid N,N-diéthylamide. Cette étude, réalisée en septembre 1985, explore la synthèse et les propriétés stimulantes analogues au LSD de divers dérivés de N(6)-alkyle de la norlysergic acid N,N-diéthylamide. Elle a été publiée dans le Journal of Medicinal Chemistry.
  3. Mise à jour de la définition générique des tryptamines par le Conseil consultatif sur l’abus de drogues (ACMD). En date du 10 juin 2014, l’ACMD a publié une mise à jour de la définition générique des tryptamines, notamment en ce qui concerne leur classification. Ce document a été émis par le ministère de l’Intérieur du Royaume-Uni.
  4. Loi sur l’abus de drogues de 1971 (Amendment) (No. 2) Order 2014. Cette loi, connue sous le nom de “The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2014,” a été émise pour apporter des amendements à la loi sur l’abus de drogues de 1971 au Royaume-Uni.
  5. Ordonnance du Conseil fédéral sur les listes des substances narcotiques, psychotropes, précurseurs et produits auxiliaires. Cette ordonnance, émise par le Conseil fédéral suisse, concerne les listes des substances narcotiques, psychotropes, précurseurs et produits auxiliaires en Suisse.

Leave a Comment

Your email address will not be published. Required fields are marked *